CALA Calithera Biosciences Inc

Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

As of 10/03/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/02/2014
Outstanding shares:  4,865,134
Average volume:  33,304
Market cap:   $14,400,797
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BQXZNP9
Valuation   (See tab for details)
PE ratio:   -0.15
PB ratio:   26.97
PS ratio:   1.13
Return on equity:   3,460.71%
Net income %:   -851.20%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy